Position in ZTS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$85,228,259
-$67,656,516 QoQ
Shares Held
1,186,032
-8.3% QoQ
Ownership
0.287%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#63
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,121,700 | $139,643,196 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
1,186,032 | $85,228,259 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
111,255 | $60,281,296 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
268,900 | $45,320,406 | |
| 5 | VTRS |
Viatris Inc
|
2,336,402 | $37,102,063 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,001,992 | $24,659,023 | |
| 7 | ALKS |
Alkermes plc.
|
316,900 | $16,605,560 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
130,654 | $14,494,754 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,228,259 | 1,186,032 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $152,884,775 | 1,293,332 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $152,674,014 | 1,213,432 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $187,777,138 | 1,283,332 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $210,584,275 | 1,350,332 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $209,505,928 | 1,272,432 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $208,539,320 | 1,279,932 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $264,609,386 | 1,354,332 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $235,012,363 | 1,355,632 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $232,652,243 | 1,374,932 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $284,100,693 | 1,439,432 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $258,592,041 | 1,486,332 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $287,682,315 | 1,670,532 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $307,869,394 | 1,849,732 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $278,830,719 | 1,902,632 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $302,450,356 | 2,039,587 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $351,942,540 | 2,047,487 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $386,456,176 | 2,049,187 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $439,641,275 | 1,801,587 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $364,437,084 | 1,877,187 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $361,088,713 | 1,937,587 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $287,849,503 | 1,827,848 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $296,931,494 | 1,794,148 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $305,710,919 | 1,848,648 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $257,408,809 | 1,878,348 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $217,567,383 | 1,848,648 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||